The development of pancreatic cancer often occurs through the accumulation of genetic mutations, including frequent mutations in the KRAS (Kirsten rat sarcoma viral oncogene homolog), p53, CDKN2A (p16) and SMAD4 (DPC4) [35]. The gene discussed is SMAD4; the disease is familial pancreatic carcinoma.